Impact of Cardiovascular Comorbidities on Clinical Outcomes Across the Asthma Spectrum
Respirology · 20.09.2026
DOI: 10.1002/resp.70317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respirology, online erschienen am 20.09.2026. Verfasst von Wen Wen Wu und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chen…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project, China International Medical Foundation.
Abstract (Originalsprache)
Background and Objective Cardiovascular disease (CVD) is a prevalent comorbidity in asthma, yet its impact on clinical outcomes across disease states remains poorly characterised.
Methods
We analysed data from two independent prospective cohorts. Cohort I comprised 1058 stable asthma patients (CVD: n = 107; non‐CVD: n = 951) followed for 12 months to assess asthma exacerbations. Cohort II comprised 825 patients hospitalised for an acute exacerbation (CVD: n = 233; non‐CVD: n = 592). Missing data were handled by multiple imputation, and the CVD and non‐CVD groups were balanced using propensity score overlap weighting. Associations were estimated using negative binomial, gamma, and logistic regression. Mediation and dominance analyses were performed as exploratory analyses.
Results
Patients with CVD exhibited greater airflow obstruction and a predominantly non‐T2 inflammatory profile characterised by increased neutrophilic inflammation. White blood cells, neutrophils, and monocytes partially mediated the association between CVD and lower FEV 1 /FVC ratio, while monocytes additionally mediated the association between CVD and severe exacerbations. In Cohort I, CVD was independently associated with severe exacerbations (adjusted IRR = 1.96, 95% CI (1.12, 3.44)), hospitalisations, and emergency visits. In Cohort II, CVD was associated with longer hospital stay (adjusted IRR = 1.14, 95% CI (1.01, 1.30)) and higher direct costs, with stroke and coronary heart disease as leading contributors to prolonged stay.
Conclusion
CVD is independently associated with worse clinical outcomes across the asthma disease spectrum. These findings support recognition of CVD as an important treatable trait in asthma and highlight the need for integrated cardiopulmonary management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Center of Excellence in Severe Asthma and Treatable Traits, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, China.
- Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, Sichuan University, Chengdu, Sichuan, China.
- Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, China.
- Department of Respiratory and Critical Care Medicine, Tongji Hospital, Huazhong University of Science & Technology, Wuhan, China.
- Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
ORCID-Profile: Wen Wen Wu, Ji Wang, Xin Zhang, Min Xie, Ling Qin, Surinder S Birring, Zhi Hong Chen, Akio Niimi, Dan Liu, Vanessa M McDonald, Feng Min Luo, Peter Gerard Gibson, Wei Min Li, Kian Fan Chung, Gang Wang
Förderung
- National Natural Science Foundation of China
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- China International Medical Foundation
Zitieren
APA
Wu, W. W., Wang, J., Ma, W. A. Q., Huang, Y. L., Zhang, X., Xie, M., Wang, C. Y., Song, W. J., Qin, L., Birring, S. S., Chen, Z. H., Niimi, A., Zhang, J., Liu, D., McDonald, V. M., Luo, F. M., Gibson, P. G., Li, W. M., Chung, K. F., & Wang, G. (2026). Impact of Cardiovascular Comorbidities on Clinical Outcomes Across the Asthma Spectrum. Respirology. https://doi.org/10.1002/resp.70317
Vancouver
Wu WW, Wang J, Ma WAQ, Huang YL, Zhang X, Xie M, et al. Impact of Cardiovascular Comorbidities on Clinical Outcomes Across the Asthma Spectrum. Respirology. 2026. doi:10.1002/resp.70317
BibTeX
@article{Wu2026,
author = {Wu, Wen Wen and Wang, Ji and Ma, Wan An Qi and Huang, Yan Li and Zhang, Xin and Xie, Min and Wang, Chang Yong and Song, Woo-Jung and Qin, Ling and Birring, Surinder S and Chen, Zhi Hong and Niimi, Akio and Zhang, Jie and Liu, Dan and McDonald, Vanessa M and Luo, Feng Min and Gibson, Peter Gerard and Li, Wei Min and Chung, Kian Fan and Wang, Gang},
title = {Impact of Cardiovascular Comorbidities on Clinical Outcomes Across the Asthma Spectrum},
journal = {Respirology},
year = {2026},
doi = {10.1002/resp.70317}
}
EUVIMED